Monoceros Biosystems, a leading bioinformatics/computational biology provider, is pleased to announce the appointment of Jonathan Spier to its Board of Directors
We are delighted to announce the appointment of Jonathan Spier, MBA, to our Board. With over 20 years of experience building category-leading companies, Jonathan is a seasoned leader whose expertise spans marketing, business operations, and strategic growth.
Currently, Jonathan serves as CEO of GetRev and Rev Intelligence, innovative companies at the forefront of AI, empowering B2B sales and marketing teams to drive more effective and efficient go-to-market strategies. Previously, he held successful CEO roles at NetBase (now Quid) and PLAE, where he demonstrated his ability to scale ventures and achieve impactful results. In addition to his leadership roles, Jonathan has mentored and advised numerous organizations as a Harvard Business School Rock Fellows Expert Mentor and New Venture Competition (NVC) Judge.
Jonathan holds a bachelor’s degree in Computer Science with honors from the University of California, Berkeley, and an MBA with honors from Harvard Business School.
Commenting on the appointment, Adam Pavlicek, PhD, CEO of Monoceros Biosystems LLC, stated:
“As we pursue our mission to provide unrivaled bioinformatics services—surpassing the capabilities of even the largest biopharma companies while serving biotech innovators of all sizes—it is essential to complement our scientific excellence with world-class marketing and business expertise. Jonathan’s experience and vision will propel Monoceros to the next stage of growth.”
Jonathan shared his enthusiasm about the new role:
“I am honored to join the board of Monoceros. I am deeply passionate about leveraging my experience to contribute to the strategic direction and growth of this unique organization.”
Please join us in extending a warm welcome to Jonathan Spier, MBA, as he begins this pivotal role. We look forward to the transformative contributions he will bring to our board and our collective success.